Research / SINT / Fundamental state Inspectable configuration
State dimensions Filing 0001493152-21-027935 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
212.97% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1081.17% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1007.53% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
262.12% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
288.70% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
20.50% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-1182.01% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
670.71% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
43.51% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 24 states Self-history eligible
Sep 30, 2021 0/9 normalized Level 3 Dec 31, 2021 0/8 normalized Level 3 Mar 31, 2022 0/8 normalized Level 3 Jun 30, 2022 0/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 7/9 normalized Level 3 Mar 31, 2023 7/9 normalized Level 3 Jun 30, 2023 7/9 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 504.95%
Current 212.97%
Delta -291.98% Capex Intensity Increased
Previous 430.69%
Current 1081.17%
Delta 650.48% Cash Generation Increased
Previous -2323.76%
Current -1007.53%
Delta 1316.23% Inventory Pressure Decreased
Previous 746.53%
Current 288.70%
Delta -457.83% Margin Decreased
Previous 27.72%
Current 20.50%
Delta -7.22% Profitability Increased
Previous -2339.60%
Current -1182.01%
Delta 1157.60% R And D Intensity Decreased
Previous 1192.08%
Current 670.71%
Delta -521.37% Sbc Intensity Decreased
Previous 79.21%
Current 43.51%
Delta -35.69% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.